Athira Pharma Inc., a biotech company based in Bothwell, Washington, has agreed to pay $4.06 million to resolve allegations related to the False Claims Act (FCA) for not disclosing research misconduct. The case stems from actions by the company's former CEO, Leen Kawas, who allegedly falsified and manipulated scientific images in her doctoral dissertation and […]